Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)

Clinical trial NCT06974344 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06974344
Sponsor: King Faisal Specialist Hospital & Research Center
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Small-for-Size Syndrome

Start date: 2025-06-01
Primary completion: 2030-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.